Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 23, 2026.

Development of Scaffolds from Bio-Based Natural Materials for Tissue Regeneration Applications: A Review

Murugiah Krishani, Wong Yen Shin, Hazwani Suhaimi and 1 more

Gels · 2023 · Review · CC BY

doi:10.3390/gels9020100

Abstract

Tissue damage and organ failure are major problems that many people face worldwide. Most of them benefit from treatment related to modern technology’s tissue regeneration process. Tissue engineering is one of the booming fields widely used to replace damaged tissue. Scaffold is a base material in which cells and growth factors are embedded to construct a substitute tissue. Various materials have been used to develop scaffolds. Bio-based natural materials are biocompatible, safe, and do not release toxic compounds during biodegradation. Therefore, it is highly recommendable to fabricate scaffolds using such materials. To date, there have been no singular materials that fulfill all the features of the scaffold. Hence, combining two or more materials is encouraged to obtain the desired characteristics. To design a reliable scaffold by combining different materials, there is a need to choose a good fabrication technique. In this review article, the bio-based natural materials and fine fabrication techniques that are currently used in developing scaffolds for tissue regeneration applications, along with the number of articles published on each material, are briefly discussed. It is envisaged to gain explicit knowledge of developing scaffolds from bio-based natural materials for tissue regeneration applications.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 23, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Introduction

Tissue regeneration is a dynamic process in which the cells and their surrounding matrix interplay. Further, this process is encouraged by designing biomaterials that adapt to the local cellular signals. Transplantation is the conventional method for tissue regeneration, but donor availability, pain, and risks related to graft rejection and infectious disease are some concerns. Tissue engineering is a modern field that promotes tissue replacement and regeneration substitutes. It is a multidisciplinary field in which a biomaterial such as a scaffold, cells, and growth factors are combined to form a new tissue. It also helps to overcome the problems faced during autologous and allogeneic tissue repair, such as inadequacy, donor site dejection, and unbidden immune responses. The scaffold acts as a template in which cells and growth factors are implanted to imitate the extracellular matrix to maintain and restore tissue function. High porosity, pore interconnectivity, biocompatibility, biodegradability, and mechanical properties are indispensable properties that must be considered when designing the scaffold. Besides blood cells, most tissue cells reside in a solid matrix known as the extracellular matrix (ECM). The ECM is an anchor for maintaining a proper structure and providing the tissue with mechanical properties and signaling molecules. Hence, the scaffold selected for engineered tissue should mimic the ECM of that specific tissue. Selecting appropriate cells, isolating and expanding targeted cells, and selecting suitable biomaterial for scaffold designing are factors that thrive in tissue engineering. However, a solitary polymer cannot achieve every single property of a scaffold, so the desired property can be attained by mixing it with a variety of polymers. Along with the selection of material, process technique or fabrication method also provide a more significant impact on the features of the resultant scaffold. This paper provides detailed information on bio-based natural materials and the fabrication techniques currently used to develop scaffolds for tissue regeneration applications.

2. Tissue Engineering

Tissue engineering (TE) is a relatively new, unique, multidisciplinary field. It offers new hope to patients by integrating clinical medicine, materials science, cell biology and genetics, and mechanical engineering to design bio-artificial tissues or biological substitutes that restore or regenerate, preserve, and improve damaged tissue or organs. The three essential parameters in tissue engineering, biomaterial scaffolds, cells, and growth-stimulating signals, are known as the “tissue-engineering triad,” as mentioned in Figure 1.

The bioreactor uses this triad to imitate a natural environment to reproduce and grow new functional tissues or cellular components. Figure 2 shows an illustration of the basic principle of TE.

Firstly, cells are isolated from a biopsy (allogenic, syngeneic, xenogeneic, or autologous source) and allowed to grow and expand in vitro, in a cell culture system, or in a bioreactor. The expanded cells are then seeded onto a nutrient and growth factors-rich matrix or carrier (scaffold) for structural support. Here, the cells grow, differentiate, and proliferate to form new tissues, then migrate to the carrier to replace the old tissues. Lastly, this TE product will be grafted into the patient to replace the damaged tissues.

2.1.1. Cells

The cell is a structural and functional unit of life in all living organisms. Cells performing the same function are grouped to form tissues and create a body system. While designing a TE product, especially for clinical applications, cell source selection becomes a crucial issue, as it determines the success of the tissue generation step. Essentially, the cells isolated for TE applications should fulfill the essential requirement of combining themselves with the selected tissue with different growth factors and cytokines that activate the endogenous tissue regeneration program. However, natural cells have difficulty reproducing the same particular cell type in large quantities. A promising cell source called stem cells is then developed as an alternative. Stem cells can be categorized into embryonic (ESCs), adult (ASCs), and induced pluripotent stem cells (iPSCs). ESCs are pluripotent cells that can differentiate into any desired lineage, but are ethically controversial and have a shortage in teratoma production. ASCs are multipotent cells and are considered more appropriate for TE applications than ESCs. Though ASCs have more limitations in cell differentiation, they are believed to be less prone to rejections after transplantations. Therefore, ASCs are commonly used to isolate tissues such as bone marrow, muscle, adipose tissue, and umbilical cord. iPSCs, on the other hand, are somatic cells in the pluripotent state that exhibit autologous characteristics and fulfill differentiation capacity. Nevertheless, iPSCs are yet to be extensively used due to the need for precise characterizations of reprogramming the somatic cells before clinical applications.

2.1.2. Growth Factors

Growth-stimulating signals include growth factors (GFs), which are a heterogeneous group of polypeptides bonded to specific receptors on the cell surface that regulates a heterogeneous group of polypeptides bonded to specific receptors on the cell surface that regulate cellular responses such as cell proliferation and cell survival, as well as the growth of targeted tissues. Some GFs that have been used in TE applications include bone morphogenetic proteins, vascular epithelial growth factor (VEGF), and transforming growth factor-β (TGF-β).

2.1.3. Scaffolds

Scaffolds play an important role in TE applications, serving as a temporary platform or template for providing guidance and structural support to develop new tissues. Scaffolds refer to a three-dimensional (3D) porous biomaterial that provides a favorable environment for cells to repair and regenerate tissues and organs. It serves as a template for tissue defect reconstruction while promoting cell attachment, proliferation, extracellular matrix regeneration, and restoration of nerves, muscles, and bones. In addition, scaffolds can transport bioactive materials such as drugs, inhibitors, and cytokines as a mechanical barrier against the infiltrating native tissues, which may disturb tissue restoration and regeneration.

2.2.1. Microarchitecture

The microarchitecture of the scaffold includes the porosity and pore size and the interconnectivity between the pores. Firstly, the pore size must be adequate for cell migration and attachment onto scaffolds. This also ensures proper mass transfer of nutrients and waste materials into and out of the cells and tissue or vascularization and infiltration. As suggested by Perić Kačarević et al., a smaller pore size is favorable, between 75 and 100 μm in vitro, while the maximum pore size should lie between 200 and 500 μm in vivo to allow optimal tissue penetration and vascularization. Moreover, an interconnecting porous system is required to provide a larger scaffold surface area for cell attachment. In addition, having a higher porosity helps to maximize cell-to-cell interactions, thereby promoting the integration of the engineered tissues with the native tissues. Alonzo et al. suggested a pore network comprising more than 60 percent of pores with pore diameters ranging between 150 and 400 μm and at least 20 percent smaller than 20 μm.

2.2.2. Biodegradability

As scaffolds only act as a temporary platform for developing cells or tissues, they should be chemically or enzymatically broken down over time when grafted into living organisms. The rate at which the scaffold materials are broken down is known as biodegradability. Ideally, the biodegradation rate of the scaffold should be proportional to the rate of new bone formation or tissue regeneration. When new tissues are successfully engineered and integrated with host bone, they will replace the biomaterial scaffolds via a “creeping substitution” step. The non-toxic products of the scaffold will then be recycled as metabolites in other biochemical reactions or exit the body without interference with other organs and surrounding tissues.

2.2.3. Biocompatibility

Furthermore, the scaffold should be highly biocompatible for cell adhesion and proliferation. There should be negligible chronic immune responses to prevent severe inflammatory reactions that might affect healing or cause rejection in the body. Even when inflammatory reactions occur, they should be recovered in no more than two weeks.

2.2.4. Bioactivity

Scaffold bioactivity refers to its ability to interact with the surrounding cellular components of the engineered tissues. Unlike traditional passive biomaterials, which generally pose low or no interactions with the environment, bioactive scaffolds are designed to enhance proper cell migration or differentiation, tissue regeneration or neoformation, and integration in the host, thereby avoiding processes such as scarring. Moreover, the scaffolds may be attached to cell-adhesive ligands to promote cell attachment, or to physical indicators such as topography to enhance cell morphology and alignment. In addition, bioactive scaffolds may serve as a transporter or reservoir for growth-stimulating signals such as GFs to enhance tissue regeneration.

2.2.5. Mechanical Properties

Furthermore, the scaffold materials should pose similar intrinsic mechanical properties as native bones or tissues in the anatomical site of implantation. The mechanical properties of tissue vary in nature, as listed in Table 1. It provides structural support and shape stability and, at the same time, helps to minimize the risk of stress shielding, implant-related osteopenia, and subsequent re-fracture. Moreover, the scaffold should also be strong enough to allow surgical handling during transplantations. Some examples of mechanical properties include elastic modulus, tensile strength, fracture toughness, fatigue, and elongation percentage.

Tensile testing and compressive testing are the conventional methods used to characterize the mechanical properties of a scaffold. Compressive/tensile strength, toughness, and Young’s modulus are the important obtained parameters. No limitations for the geometrical structure of the specimen is the biggest advantage of compressive testing over tensile testing. Atomic force microscopy (AFM), dynamic mechanical analysis (DMA), rheometry, and micro indentation are the alternative methods for the characterization of mechanical properties. Elasticity (Young’s modulus), shear strength, and viscoelasticity measurement are some significant mechanical properties in cardiac tissue engineering. Due to its thin geometric structure (µm thickness), it is inadequate for DMA. Hence, viscoelasticity measurement for the cardiac scaffold is incorporated only in a few studies. For the healing process, to endure osteogenic loads, adequate compressive strength is needed in bone tissue engineering. Compared to other tissues, neural tissues have low mechanical stiffness with the range of 0.1KPa for Young’s modulus. Mechanical properties play a crucial role in skin tissue engineering to resist physiological forces such as nerve bundles, vascular networks, and collagen deposition during the wound healing process. Figure 3 depicts the requirements to be considered while developing the scaffold.

2.2.6. Manufacturing Technologies

As stated by Place et al., TE products must be both productive and cost-effective, introducing a potential dichotomy between the need for sophistication and ease of production. While ensuring scaffold efficiency, it is also essential to consider the cost and availability, ensuring scale-up production of the scaffolds is feasible when required. Another key factor to consider is delivering and packaging the scaffolds to the clinicians. Even though clinicians usually prefer off-the-shelf availability to lessen waiting time before implantations, it may not be possible for some tissue types. Therefore, this should be considered while implementing a TE strategy.

2.3. Materials Used for Developing Scaffold

The material source for scaffolds should depend on the patient’s status. For instance, patients with cancer or osteoporosis generally experience low bone metabolism; hence, the scaffold material should be non-resorbable. Nevertheless, the material source would come under biomaterials. According to the European Society for Biomaterials (ESB), a biomaterial is a material meant to interface with biological systems to treat, evaluate, augment or replace any tissue, organ or function of the body. The four major biomaterials typically used in the fabrication of scaffolds are polymers, bio-ceramics, metals, and carbon-based nanomaterials. As each group has specific advantages and disadvantages, scaffolds may comprise more than one of these biomaterial types. Natural polymers, synthetic polymers, bio-ceramics, biodegradable metals, and carbon-based nanomaterials are currently used in scaffold development.

2.3.1. Polymer

A polymer is a long-chained macromolecule built up by repeated monomers, and polymer-based biomaterials are considered a good choice for fabricating a scaffold. Polymers are a good candidate in TE applications for their great versatility and flexibility in providing a wide range of mechanical, chemical, and physical properties. They show good biocompatibility, are light in weight, and are resistant to biochemical attack. Moreover, polymers are highly available at a reasonable cost and quickly processed into desired shapes. In addition, the inertness of polymers towards host tissues makes them an eligible candidate for a drug delivery system. Some biomedical applications involving polymers include artificial organs and blood vessels, breast implants, contact lenses, coatings for pharmaceutical tablets and capsules, external and internal ear repairs, cardiac assist devices, and joint replacements. Polymeric biomaterials have been obtained from natural and synthetic polymers, each having pros and cons. Carbohydrates such as chitin, cellulose, starch, alginate, and hyaluronic acid and proteins such as collagen, elastin, keratin, gelatin, and fibrin fall under natural polymers, where polyesters such as poly ε-caprolactone (PCL), polylactic acid (PLA), and polyglycolic acid (PGA) and Polyurethanes come under synthetic polymers.

Natural polymers: Biopolymers are toxic-free, highly biocompatible, easily adhere to cells, and improve proliferation and differentiation. Nevertheless, they have poor mechanical strength and are highly sensitive to elevated temperatures. Biopolymers are also known as natural polymers. Natural polymers are materials that can be obtained from natural sources. They can be categorized into protein-based biomaterials (naturally occurring polymers in the human body such as collagen, fibrin, and elastin) and polysaccharides-based biomaterials (such as silk, chitosan, alginate, and gelatin). They exhibit similar characteristics to soft tissues, showing bioactivity, excellent cell adhesion and growth, and fulfilling biodegradability and biocompatibility. Moreover, they are also known for their wide availability, ecological safety, and modifiability to suit different applications. However, natural sources indicate the requirement of a purification step to avoid foreign immunological responses after implantation. In addition, natural polymers typically show poor physical and mechanical stability, limiting their applications in the load-bearing orthopaedic field.

Synthetic polymers: In contrast to natural polymers, synthetic polymers have good mechanical properties. However, they also have a high risk of immune rejection, and toxic substances such as carbon dioxides are released during degradation, leading to cell damage. Synthetic polymers serve as a more predictable biomaterial providing a wide range of mechanical and physical properties such as degradation rates. If they are synthesized under controlled conditions, they do not pose any immunological risks, and desired characteristics can be brought together. One common synthetic polymer used for BTE applications is aliphatic polyesters, including poly (ε-caprolactone) (PCL) and polylactide (PLA). PCL is a semi-crystalline, biodegradable, and non-toxic polyester that shows hydrophobicity and slow degradation rates of more than 24 months. These problems can be addressed by blending with other polymers or producing composites. In contrast, the porous PLA exhibits high biocompatibility, but shows slow degradation rates of 3–5 years. Thus, PLA is combined with hydroxyapatite (HAp) to improve its mechanical and physical strength.

2.3.2. Bio-Ceramics

Ceramic materials obtained from natural products, termed bio-ceramics, have been widely used in dental and bone tissue engineering. Bio-ceramics are organic, non-metallic solids with good compatibility, bio-inertness, bioactivity, osteoconductivity, and mechanical strength. In addition, bio-ceramics can promote new bone generation and the osteo-potential of scaffolds. However, bio-ceramics are low in elasticity with a brittle surface, limiting their use in implants. Thus, they are usually blended or coated with other materials to improve their elasticity and strength. Among the biomaterials, bio-ceramic scaffolds have been proven to be more successful in treating minor bone defects, such as orthopaedic implants and bone-filling applications. There are three main types of ceramics: bioinert, bioactive, and bioresorbable. Bioinert ceramics include alumina (Al2O3), Zirconia (ZrO2), and pyrolytic carbon; bioactive ceramics include bioglasses (BG) and glass ceramics, while bioresorbable ceramic contains calcium phosphates. Of all three types, the most commonly used ceramics in BTE applications are HAp, tricalcium phosphates (TCP), and their composites. Human bone and teeth are composed of an inorganic compound known as hydroxyapatite, which constitutes calcium, phosphate, and OH radicals with high tensile strength and quickly adheres to host tissues. Many studies revealed that HAp is non-toxic and lacks inflammatory and pyrogenetic response.

HAp is a naturally occurring calcium phosphate-based mineral with the chemical formula Ca10(PO4)6(OH)2. It is structurally similar to a biological apatite in the human body, known as bone mineral, which makes up approximately 60–70% of human bone tissues on a dry weight basis. It shows similar chemical and physical properties to human bone and dental tissues. Hence, some hydroxyapatite-rich natural products such as shells, corals, algae, fish scales, and animal bones are used to develop scaffolds. HAp exhibits excellent biocompatibility and bioactivity, high osteoinductivity and osteoconductivity, non-toxicity, and non-inflammatory characteristics. Moreover, it vitalizes growth factors and promotes cell growth and proliferation. HAp is therefore considered a highly potential implant material and bone substitute. Nevertheless, HAp also shows poor mechanical properties, slow resorption and remodeling rates, and slow degradation rates in vivo, making it unsuitable for all BTE applications. Thus, HAp is usually synthesized with other natural or synthetic polymers to create more effective composite scaffolds.

HAp can be obtained through extractions from natural sources or chemical syntheses, divided into three categories: high-temperature methods, wet methods, and dry methods. Dry methods include mechanochemical methods and solid-state reactions. Here, dry precursors of calcium and phosphate are mixed without any precisely controlled conditions to synthesize HAp. According to Sadat-Shojai et al., this is to ease the mass production of HAp powders. Wet methods include sol-gel, chemical/wet/co-precipitation, hydrothermal, hydrolysis, sonochemical method, and emulsion method. With this method, the morphology and average powder size can be controlled. However, HAp yielded usually exhibits low crystallinity due to low operating temperatures. High-temperature processes include combustion and pyrolysis methods, where samples undergo thermal decompositions. These two methods are rarely used for HAp synthesis due to poor control over the operating conditions.

HAp can also be extracted from food wastes or biological sources such as aquatic or marine sources, mammalian bones shell sources, and plant sources. This method is relatively safe, more sustainable, and economical to fabricate HAp, thereby contributing to the economy, environment, and general health. However, it is notable that natural HAp is non-stoichiometric, either calcium or phosphorus-deficient. Generally, calcium positions would be the vacancy, where cations such as Na+, Mg2+, and Al3+ are substituted into the vacant space. Likewise, carbonate ions would replace phosphate or hydroxyl ions, and fluoride ions would substitute in place of hydroxyl ions. These trace elements present in the natural HAp resemble the apatite in human bone, which is crucial in accelerating bone formation and regeneration. For instance, blending 3–5 mol% silicon with synthetic HAp can boost cell growth density, enhancing osteoblast growth. Another example is adding 1–10% of strontium ions in synthetic HAp, which improves osteoblast activity and material differentiation. Calcium carbonate is abundantly found in the exoskeleton of most marine organisms such as corals, sea urchins, and some algae. HAp produced from these exoskeletons are highly porous, have good vascularization and blood supply, and help to form new tissue. Over the past 20 years, extensive research has been done to constantly improve the synthesis methods and introduce new technologies, aiming to develop an ideal HAp composite or scaffold that fulfills all the desired specifications.

2.3.3. Metals

Metals such as stainless steel, cobalt–chromium–molybdenum alloy, aluminium, lead, silver, and titanium alloys have been considered good load-bearing implants because of their excellent quality electrical and thermal conductivity, appropriate mechanical properties, corrosion resistance, biocompatibility, and reasonable cost. However, metals are non-biodegradable. Therefore, researchers introduced the use of biodegradable metals. Biodegradable metals are metals having controlled corrosion properties. They can be grouped into pure biodegradable metals (Mg−- and Fe--based), biodegradable alloys, and biodegradable metal matrix composites. Pure biodegradable metal implants have similar mechanical properties to stainless steel and bone and are non-toxic. However, they show slow degradation rates and are incompatible with MRI (Magnetic Resonance Imaging). These problems can be addressed through newly-developed fabrication methods such as casting, electroforming, powder metallurgy, and inkjet 3D printing. Moreover, it is essential to note that the patients implanted with biodegradable metals should not have an iron-related disease, and the patient’s intestines can absorb only Fe2+. Thus, any Fe3+ released should be first reduced to Fe2+ before being absorbed.

Biodegradable porous metal scaffolds have attracted researchers in scaffold development by their high compressive strength. Biodegradable metals overcome problems such as innate immune rejection and have good load-bearing capacity during bone healing. However, biodegradable metals such as Mg and their alloys have a high corrosion rate. Recently, scientists have concentrated on the Zn-based alloy system to produce biodegradable metal scaffolds.

2.3.4. Carbon-Based Nanomaterials

Researchers developed carbon-based nanomaterial scaffolds by combining tissue engineering and nanotechnology to enhance the scaffold’s features. Carbon nanotubes (CNTs), graphene oxide (GO), carbon dots (CDs), fullerenes, and nanodiamonds are some carbon nanomaterials used as scaffolds in tissue engineering. Biocompatibility, mechanical stability, low cytotoxicity, facilitating cell communication, and nutrition delivery are advantages of carbon-based nanomaterials that pull down to use in scaffold development. However, limited biodegradability and potential cytotoxicity are significant drawbacks.

Carbon-based nanomaterials, including graphene oxide (GO), carbon nanotubes (CNTs), fullerenes, carbon dots (CDs), nanodiamonds (NDs), and their derivatives, are highly potential scaffold materials for bone restoration applications. They are biocompatible, mechanically stable, and commercially available. In addition to that, they show essential qualities such as good biodegradability, efficient cell proliferation and osteogenic differentiations, significant cell growth stimulations, proper mass transfer of nutrients in the scaffold microenvironment, improved cell distributions, and appropriate cell bioactivity. Yet, further studies regarding the low cytotoxicity and the adverse environmental effects of carbon-based nanomaterials are to be conducted before they can be clinically tested and brought into application. The materials used for developing the scaffold are summarized in Figure 4.

In recent years, some innovative synthetic scaffolds based on natural products have been developed by applying recombinant DNA technology and advanced genetic engineering. Elastin-like recombinant [ELR] and elastin-like peptides [ELP] are a few scaffolds developed by obtaining the principles of advanced genetic engineering techniques. The Arginine, Glycine, and Aspartic acid (RGD) sequence is an integrin-binding sequence in the ELP scaffolds, which helps in cell adhesion and proliferation. ELR scaffolds constitute a fibronectin domain that helps cell adhesion, particularly in vascular regeneration. B. Gurumurthy et al. developed a collagen-based scaffold by incorporating it with an elastin-like polypeptide obtained from genetically modified Escherichia coli bacteria and bioglass to examine the osteogenic differentiation. Repeated sequences of elastin and silk blocks are recombinantly combined to form silk-elastin-like protein polymers (SELPs). The hydrogels of SELPs play a vital role in wound healing.

On the whole, bio-based polymers have good features such as compatibility, versatility, and adaptability, and are also abundant in nature; they can be obtained from various agricultural resources and biodegradable waste materials. Hence, the processing and synthesis cost is low and environmentally friendly. Many researchers have tried to produce scaffolds from natural polymers by keeping this in mind by modifying and enhancing their stability using various fabrication methods.

2.4.1. Cellulose

Cellulose is a fundamental structural unit of the plant cell wall. It is also found in red, green, and brown algae, some fungi, and as an extracellular component in bacteria. Cellulose is a homopolysaccharide composed of D-glucose units connected by β-(1→4) glycosidic bonds. Cellulose is an ideal material for tissue growth. It has several features such as biocompatibility, biodegradability, and cheap cost. It is already used as a scaffolding material in wound repair, cartilage tissue regeneration, differentiating endothelial cells, and bone tissue engineering. Scaffolds developed based on bacterial cellulose are widely used in various biomedical applications. Based on recent research, the performance of the material toward cell growth or biocompatibility is mentioned in Table 2.

2.4.2. Chitin and Chitosan

Chitin is the second most common polysaccharide globally, followed by cellulose. It exists in the exoskeleton of arthropods such as crabs, shrimps, lobsters, insects, prawns, and fungal cell walls. Chitin comprises repeated units of 2-(acetylamino)-2-deoxy-D-glucose. Chitin and chitosan are differentiated by a degree of deacetylation. Chitin has various biomedical applications in tissue engineering due to its outstanding properties such as non-toxicity, biocompatibility, biodegradability, and chelating of metal ions. It also supports cell adhesion, differentiation, and migration. Chitin also has structural similarity with N-glycosaminoglycans, essential components of connective tissues; hence, it is a good option for skin tissue regeneration. Further, it is also used in dental, bone, and cartilage implants. Mokhtari et al. have developed a scaffold hydrogel by combining chitosan with collagen and aldehyde-modified nanocrystalline cellulose loaded with gold nanoparticles, showing a potential application in tissue engineering.

2.4.3. Alginate

Alginate is a seaweed-derived polysaccharide extracted from Phaeophyceae-brown algae. Alginate comprises β-(1–4)-d-mannuronic acid and α-(1,4)-l-guluronic acid connected as repeated linear chains. Alginate displays biocompatibility, biodegradability, a simple production process, and tunable mechanical properties, leaping to join in developing scaffolds in cartilage tissue engineering. Moreover, alginate is hydrophilic, so it is used in wound dressing to absorb the pus and help it heal. It is also used in cell growth scaffolds, supporting blood vessels’ formation, healing bone injuries, cartilage regeneration, and drug delivery systems. Alginate-based scaffolds are widely used in various tissues or organs, including skeletal muscles, pancreas, nerve, liver, and dental tissue engineering. For cardiac repair, Rosellini. E. et al. produced a scaffold using alginate, elastin, and gelatin, which successfully attained the desired cellular response. The molecular structure of some polysaccharides is shown in Figure 5.

2.4.4. Starch

Starch is a popular polysaccharide produced by plants for energy storage. It consists of amylose and amylopectin. Amylose (a linear polymer linked by α (1–4) linkages) is connected to amylopectin (highly branched polymer) by α (1–6) linkages. Starch is highly porous and allows cells to penetrate vascularization and tissue growth. Biocompatibility, biodegradation, osteoconduction, and osteo production are some characteristics that display starch to apply in tissue engineering.

A study revealed that starch membrane, collagen, and chitosan enhance epithelial tissue regeneration during wound healing, clearly showing that starch-based scaffolds have more significance in wound healing. It also helps in cell adhesion, growth, proliferation, and differentiation. Starch generally shows poor mechanical properties in aqueous media and is easily dissolved. Starch was incorporated with bio-additives to attain good mechanical properties to overcome this problem. For instance, researchers combined starch-based scaffolds with bio-additives such as citric acid, cellulose nanofibers, and hydroxyapatite to obtain the desired result. Many in vivo and in vitro assessments certified that starch-based scaffolds are better for bone regeneration. The molecular structure of starch is shown in Figure 6.

2.4.5. Hyaluronic Acid

Hyaluronic acid is a glycosaminoglycan that deficits sulfate bonds commonly secreted by chondrocytes and fibroblasts. It comprises repeated β-1,4-D-glucuronic acid and β-1,3-N-acetyl-D-glucosamine disaccharide units. It is mainly present in the synovial fluid, connective tissues of the dermis, the vitreum, and the dental pulp matrix. It maintains the viscoelasticity of ECM by acting as a lubricant. It plays a vital role in the cell’s structural maintenance, keeps tissue hydrated, and helps cell signaling and wound repair. It is highly biocompatible, biodegradable, and can be easily modified chemically. Therefore, it is widely used as scaffolds in various forms such as sponges, cryogels, hydrogels, and injectable hydrogels. A combination of collagen and hyaluronic acid scaffold material was used in cartilage regeneration, which plays a significant role in tissue repair. Mohammadi et al. prepared a scaffold by combining hyaluronic acid and collagen loaded with prednisolone to make a proper dosage form for cartilage repair. According to Sieni et al., scaffolds based on hyaluronic acid show several more valuable features than collagen scaffolds in breast cancer treatment. The advantages, disadvantages, and applications of each polysaccharide are mentioned in Table 3.

2.4.6. Guar Gum

Guar gum is a galactomannan gum, a polysaccharide obtained from the seed of a leguminous plant, namely, guar beans, commonly known as cluster beans (Cyamopsis teteragonolobha). Easy accessibility, biodegradability, biocompatibility, non-toxicity, and non-immunogenicity are attractive features that tempt many researchers to develop scaffolds from guar gum.

2.4.7. Pullulan

Pullulan is a polysaccharide made up of repeated maltotriose units connected by alpha (1–6) linkages obtained from fungi known as Aureobasidium. Pullulan plays a vital role in tissue engineering due to its adjustable property, biocompatibility, biodegradability, and adhesive nature. Oxidized pullulan was cross-linked with collagen, and scaffolds were produced for various biomedical applications.

2.4.8. Collagen

Collagen is the critical protein in the connective tissues of animals, mainly in mammals. It is a protein with high biocompatibility and biodegradability. Therefore, it is applied in the medical field in various forms, such as a scaffold, drug carrier, and wound dressing. The latest research shows that collagen obtained from marine organisms is used in multiple biomedical applications. Collagen-based scaffolds are widely used in myocardial tissue engineering, cartilage tissue engineering, neural tissue engineering, musculoskeletal tissue engineering, and bone tissue engineering. Massimino et al. developed a collagen-based scaffold obtained from bovine tendon for dermal regeneration applications. Pericardial bovine and porcine tissue underwent TRICOL decellularization (detergent-based treatment), and decellularized pericardial scaffold containing collagen and elastin was considered a potential biomaterial for tissue replacement.

2.4.9. Fibroin

Fibroin is protein silk produced by some larvae such as spiders, silkworms, mites, scorpions, and flies. The silk obtained from Bombyx mori (silkworm) and spiders such as Araneus diadematus and Nephila clavipes are widely used commercially. Due to its excellent structural integrity and mechanical properties, silk fibroin-based biomaterial is used in musculoskeletal tissue engineering. Hadisi et al. developed a silk fibroin-based scaffold composed of hardystonite loaded with gentamicin as an antibiotic agent to evaluate the in vitro and in vivo studies on bone tissue engineering applications. According to Zakeri-Siavashani et al., fibroin-based scaffold containing keratin and vanillin particles acts as a potential antibacterial agent in skin tissue engineering.

2.4.10. Keratin

Keratin is a fibrous protein rich in cysteine and is widely present in hair, nails, wool, feathers, and horns. The flexible transverse bonds in the keratin molecular chain provide suitable mechanical properties to its fibrous protein structure. Keratin is insoluble, highly durable, chemically unreactive, and has binding factors that help cell adhesion and growth. Keratin-based scaffolds are widely used in skin, bone, and nerve regeneration. Wan et al. developed a biocomposite mat that constitutes poly (ε-caprolactone), keratin, heparin, and vascular endothelial growth factor, which acts as a well-suited scaffold in vascular tissue engineering. The molecular structure of some protein molecules is shown in Figure 7.

2.4.11. Elastin

Elastin is a structural protein with elastic properties widely found in connective tissue and other load-bearing tissues. Elastin is in the collagen network in many organs, including the lungs, skin, and blood vessels. In vascular tissue engineering, the successful development of elastin-based vascular graft materials helps to facilitate arterial regeneration and helps to understand the macrophage-mediated immune response created after implantation. Rodrigues I. C. P. et al. stated that adding elastin and collagen to his polyurethane-based scaffold improves cellular response and wettability. Matriderm and glyaderm are some dermal substitutes used in wound healing made up of elastin combined with collagen, whereas matriderm constitutes bovine collagen.

2.4.12. Fibrin

Fibrin is a protein molecule formed during blood clotting by polymerizing thrombin and fibrinogen in blood plasma. Easy fabrication, rapid biodegradability, and good biocompatibility are some properties that make fibrin used in tissue regeneration applications. It is mainly used in nerve tissue engineering, skin tissue engineering, musculoskeletal tissue engineering, and cardiac tissue engineering. According to Bluteau et al., the low thrombin concentration increased the rate of osteoblastic marker expression. It brought out the increased angiogenic response of osteoblasts by vascular endothelial growth factor (VEGF) expression. Thus, fibrin also helps in bone tissue engineering.

2.4.13. Gelatin

Gelatin is a protein molecule obtained by the hydrolysis of collagen, and it constitutes the Arg–Gly–Asp (RGD) peptide sequence, which helps in cell adhesion, proliferation, and differentiation. The primary source of gelatin production is extracted from mammals, especially bovine hides and porcine skin. Scaffold coated with gelatin inhibits complement system and opsonization. Thus, it reduces their immunogenicity. In vitro studies show that scaffolds based on gelatin can control cell differentiation and gene expression. Dehghan M. et al. combined gelatin, polycaprolactone, and polydimethylsiloxane to produce a scaffold, and further investigations on tests regarding biocompatibility, biodegradability, and mechanical properties gave a positive result.

Singh S. et al. used gelatin as a fabricating material for a cellulose-based scaffold produced from cotton to improve cell adhesion. Goudarzi Z. M. et al. concluded that a poly (ε-caprolactone) and gelatin composite scaffold incorporated with acetylated cellulose nanofiber is an ideal scaffold for soft tissue engineering. The list of advantages, disadvantages, and applications of each protein is mentioned in Table 4.

Figure 8 and Figure 9 depict the number of publications on polysaccharides and proteins in tissue engineering applications. It can be seen from both figures that there is an apparent increase in terms of publications in research involving the usage of polysaccharides and proteins as a natural ingredient in developing suitable scaffolds for tissue engineering applications

2.5. Scaffold Fabrication Techniques

Usually, the tissue comprises repeated 3D units such as islets that act as a base for coordinating multicellular processes, maintaining mechanical properties, and integrating various organs through the circulation process. Hence, while designing the scaffold for tissue repair, we must remember that tissue substitutes should have desired mechanical properties and facilities for transporting nutrients and wastes. Fabrication techniques are needed to create a proper scaffold with good mechanical properties, interconnected pores, 3D porous structure, and uniform distribution. The scaffold architectural design is characterized into three levels (nano, micro, and macro) to maintain scaffold parameters such as anatomical features, cell–matrix interactions, and nutritional transportation. The nano-level architecture includes surface modification, including attachment of signaling molecules for cell adhesion, proliferation, and differentiation. Micro-level architecture constitutes pore size, porosity, interconnected pores, and spatial arrangements. The anatomical features and organ and patient specificity include macro-level architecture.

Fabrication techniques are classified into two categories: conventional and rapid prototyping. Techniques such as freeze drying, solvent casting, particle leaching, electro-spinning, gas foaming, and thermal-induced phase separation come under conventional fabrication techniques. These techniques are suitable for constructing porous scaffolds, but the main limitation is the lack of tunable properties to control shapes and internal architecture. In other words, achieving complex micro- and macro-level architecture is difficult in conventional fabrication techniques. Rapid prototyping is developed to overcome the drawbacks caused by conventional fabrication techniques. Rapid prototyping is known as solid free-form fabrication (SFF) and additive manufacturing (AM). It is the fastest fabrication method for assembling the desired item by using computer generation tools such as computer-aided design (CAD), magnetic resonance imaging (MRI), and computer tomography (CT). Nearly 30 rapid prototyping technologies were applied in various fields, of which 20 were used for biomedical applications. Stereolithography, bioprinting, selective laser sintering, solvent-based extrusion-free forming, and fused deposition modeling are standard rapid prototyping methods used in tissue engineering for scaffold fabrication.

Usually, the primary protocol includes forming and slicing a virtual computer model ensured by layer-by-layer fabrication steps that are similar in all the various rapid prototyping techniques. Initially, a CAD model is captured or formulated from a physical unit by digital method, and then the obtained model is converted into a stereolithography file for virtual slicing. Further, it allows for digital slicing to gain cross-sectional layers. This process is termed pre-processing. Then, rapid prototyping starts to print the layer of the prototype. The post-processing steps, including surface treatment and hardening, are applied. It entirely depends on the purpose and manufacturing techniques. The desired complex micro- and macro-level architecture can also be achieved by using rapid prototyping.

2.5.1. Freeze Drying

The freeze-drying technique is otherwise known as lyophilization or ice templating. This technique includes three steps: dissolution, solidification or freezing, and sublimation. At first, the chosen polymer is dissolved in a solvent. Secondly, the solution is loaded into a mold and placed in the freezer for solidification or freezing. It is then allowed to cool down using chemicals such as dry ice in aqueous methanol, liquid nitrogen, or mechanical refrigeration. Care should be taken at this step to maintain temperature, or else it will result in the formation of large crystals, which may affect the properties of the scaffold later. Thirdly, the sublimation process is carried out to remove water and other solvent molecules in the frozen component. This technique is highly suitable for producing scaffolds with high porosity, which provides vascularization and helps in cell proliferation and differentiation. The lyophilization method can be combined with salt leaching, gas foaming, gel casting, and liquid dispensing practices to improve the scaffold’s properties. No involvement of heat is the primary advantage of this method, so heat-sensitive molecules such as proteins or growth factors can be incorporated into it without hesitation. However, it consumes a longer time and high energy, and the cost of a freeze dryer is expensive, which are some of the drawbacks. C. M. Brougham et al. developed a heart valve-shaped tissue engineering scaffold using collagen and glycosaminoglycan copolymer and fabricated it using the freeze-drying method. During electro-spinning, toxic substances from organic solvents may involve scaffold preparation. Moreover, it can cause damage to the biological activity of cells. To avoid this situation, A. Izadyari Aghmiuni et al. combined freeze-drying and electro-spinning methods to develop a scaffold for tissue engineering.

2.5.2. Solvent Casting and Particle Leaching

3D specimens with thin walls or membranes were produced using solvent casting and particle leaching methods. These thin membranes are prepared by adding salt particles to the solvent polymeric solution. Then, the solvent is allowed to evaporate, and the resulting membrane is washed with distilled water to leach out the salt. The main advantages of solvent casting and particle leaching methods are high porosity, cheapness, and straightforwardness. This technique’s usage of toxic solvents, poor interconnectivity, and irregularly shaped pores are limitations. N. Thadavirul et al. developed a polycaprolactone porous scaffold using solvent casting and particle leaching techniques for bone tissue engineering. To enhance the mechanical properties, researchers incorporate hydroxyapatite into blends of the biodegradable polymer.

2.5.3. Gas Foaming

The gas foaming technique was introduced to avoid using organic cytotoxic solvents and high temperatures. However, the resultant material obtained had closed pores, which limited its usage, especially in cell transplantation. In this method, chosen polymer was mixed with salt particles and molded to form solid disks. Then, disks were exposed to inert gas foaming agents such as nitrogen gas or carbon dioxide with high pressure for saturation. Then, gas was decreased to ambient pressure to create thermodynamic instability, resulting in nucleation and facilitating carbon dioxide pores between polymer matrices. Finally, the salt was removed by leaching the polymer using distilled water.

2.5.4. Electrospinning

It is a simple technique in which solutions produce fibers by applying high-voltage electricity. The main principle behind this technique is the interaction between electrostatic repulsion and surface tension of charging liquid that receives high voltage droplets. This machine consists of four major parts: a power supply unit, a syringe pump, a metallic needle, and a grounded collector, as shown in Figure 10. Usually, this technique is widely used for producing nano-fibrous scaffolds. The liquid is injected into the capillary tube of the syringe pump. The muscle power of the electric field from a high-voltage power supply increases the surface tension of liquid extruding from the nozzle of the metallic needle.

Further, the liquid jet is continuously whipped due to electrostatic repulsion and is collected in the form of fibers in the grounded collector. Electrospinning techniques help produce scaffolds with good porosity, patterned architecture, and aligned fibers, which further help cellular response and enhance tissue regeneration. Precise control over fiber formation, homogeneous cell distribution, and lack of cellular infiltration are drawbacks of the electrospinning method. Cellulose nano fiber (CNF) scaffolds developed using potato peel waste promote the adhesion and proliferation of BALB-3T3 fibroblasts cells.

2.5.5. Thermal-Induced Phase Separation Method

This method is widely used to fabricate microcellular foams or microporous membranes. This technique de-mixes the homogenous polymer solution into polymer-rich and poor phases by applying variant temperatures. Further, lyophilization of phase-separated polymer solution helps produce microcellular structure. Adjustment of pore size can be practically made possible in this method by allowing drugs and fillers. Moreover, these particles are also homogeneously distributed within the pore size. Inadequate resolution and usage of limited materials for fabrications are the main drawbacks of this method. The phase separation technique plays a vital role in fabricating a 3D nanofibrous scaffold, and it can be highly recommended to use along with another fabricating technique such as solid free form. The advantages and disadvantages of various fabrication techniques are mentioned in Table 5.

2.5.6. Stereolithography

Stereolithography is considered the first rapid prototype technique commercially available in the fabrication process—an aqueous photo-curable polymer was used as a raw material. An ultraviolet laser beam was used as a light source to irradiate the material surface for solidification where the untreated region remains liquid. Once the solidification of one layer is completed, the lifting table starts to move to the next layer. Subsequently, the solidified layer is recoated with new liquid resin. This photo-polymerization process is repeated until the remaining layer is done. This technique’s scaffold material has enhanced cell growth and adhesion. High resolution and uniformity in pore interconnectivity are this method’s main advantages. The process involved in stereolithography is shown in Figure 11.

2.5.7. Selective Laser Sintering

It is an additive manufacturing technique in which a high-intensity laser beam fabricates a scaffold layer-wise using computer-aided design models. Usually, materials are used in powder, and this technique can be applied to produce various materials such as ceramic, polymer, and metals. The laser beam is used to heat powder particles to glass transition temperature (near their melting point). The material was sintered to form a solid model directly without permitting the melting phase. Then, the workstation moves down layer by layer. At the same time, fresh powder is spread on the sintered object with the help of a roller, and the process is repeated until the completion of a 3D material. The scaffolds from this method provide excellent compressive strength, fracture toughness, osteoconduction, and osteoinduction. However, the high operating temperature limits the resolution, and additional procedures such as removing injected powder after processing the phase spin are some drawbacks of this method. The process involved in selective laser sintering is shown in Figure 12.

2.5.8. Fused Deposition Model

According to Xia et al., the fused deposition model is a filament-based additive manufacturing method. Plastic materials are used in the form of filament. They are inserted into a heating nozzle, where the filament is melted, extruded, and deposited into a plate to produce a 3D structure, layer-by-layer manner, with the help of computer-based devices. This technique is simple, cheap, versatile, and has wide applications. However, some significant deficiencies are there, too, such as difficulty in microporosity establishment, which results in a lack of cell growth and vascularization. The processing time is too long, and the heating process hinders the integration of biomolecules into the scaffold, resulting in a smooth surface unsuitable for cell adhesion, which needs further coating. Many experiments were carried out to overcome these problems, and some series were developed based on the fusion deposition model. Low-temperature deposition modeling is one of the series created, and it also gave positive responses such as better biocompatibility, biodegradability, and all required properties for bone tissue engineering.

2.5.9. Solvent-based Extrusion 3D Printing Method

The solvent-based extrusion 3D printing method keeps biomaterials in solvents to produce inks. Then, obtained inks are extruded from the nozzle in filament to create a scaffold structure in a layer-wise manner. Natural polymers, synthetic polymers, and ceramics are the biomaterials currently being used to produce ink. This technique was widely applied to fabricate scaffolds for cartilage tissue, bone tissue, blood vessel, heart valve tissue, and skin tissue. Difficulty in obtaining appropriate levels of filament uniformity, lack of ink feasibility, and poor fidelity between the structure of computer models and printed scaffold structures are some disadvantages.

2.5.10. Bioprinting Method

Bioprinting technology is a promising fabrication technique to develop highly mimicked tissue with digital control. A typical bioprinting method consists of pre-processing, processing, and post-processing phases. At first, in the pre-processing step, the tissue blueprint is created using computer-aided design (CAD). The vital information regarding histological structure and composition, anatomy, and human organ topology for the design can be extracted using imaging approaches. Moreover, parameters for biomaterials are also finalized during this stage. A suitable bioprinter prints the desired structure in the processing step. The bio-ink used for the bioprinter plays a crucial role in delivering the desired scaffold. Finally, post-processing steps are carried out to maturate the obtained scaffold before host implantation. Using an ideal bioreactor for the scale-up process is also under this category. Computer-aided design (CAD) and computer-aided manufacturing (CAM) are used in all three phases and play a crucial role.

Bio-CAD mimics the 3D internal structure, differentiates heterogeneous tissue types, and creates desired models. Bio-CAM is used to predict the feasibility of the fabrication process. The combination of Bio-CAD and Bio-CAM helps accelerate the bioprinting process and enhance the quality of printed tissues. The biomaterials used in this process should be printable, non-toxic, and biodegradable in vivo. Inkjet bioprinting, extrusion bioprinting, laser-assisted bioprinting, and stereolithography are the widely applied bioprinting approaches. Due to their advantages, low cost, accuracy, and high speed, bioprinting technologies have already marked their footprints in cartilage, skin, aortic valve, bone, vascular, and kidney tissues. Dependence on existing cells is the main drawback of this method.

2.5.11. Aerosol Jet Printing

The focused airstream is used as ink instead of liquid droplets in aerosol jet printing. Either organic or inorganic materials can be used for this printing technique. A composite suspension is atomized into an aerosol using an ultrasonic or pneumatic atomizer. Then, it is transported to the deposition head by nitrogen gas, which acts as a carrier gas, and jets onto the substrate to form a 3D structure in a layer-wise manner. Polymer, ceramic, and metals can be used for aerosol jet printing. Scaffolds developed from aerosol jet printing show better cytocompatibility in in vitro studies, and it is a low-temperature process, so it is suitable for biomanufacturing too. Some research on natural polymers used to fabricate scaffolds for various tissue regeneration applications is explained in Table 6.

3. Conclusions

Scaffolds based on natural products have gained more importance than synthetic products. The research in developing scaffolds from natural-based biomaterials for tissue regeneration applications is rapidly growing due to their outstanding properties such as promoting cell adhesion, proliferation, migration, biocompatibility, biodegradability, porosity, ease of production, inexpensive, and non-toxic. However, natural-based biomaterials have poor mechanical properties. They can be fabricated with suitable materials and used in various biomedical applications, including tissue engineering. The selection of suitable materials is crucial in tissue engineering. In that way, this paper provides a clear idea about the natural-based materials that are currently used in tissue engineering applications. In addition to that, the applications of fabrication techniques in scaffold development have been illustrated. Each technique has its respective benefits and drawbacks, and, as mentioned, appropriate selection to satisfy the need for the tissue to be repaired plays a vital role.

References 253

  1. 1.

    Koons G.L., Diba M., Mikos A.G. Materials design for bone-tissue engineering. Nat. Rev. Mater. 2020;5:584-603.

    Not in our library10.1038/s41578-020-0204-2

  2. 2.

    Eltom A., Zhong G., Muhammad A. Scaffold Techniques and Designs in Tissue Engineering Functions and Purposes: A Review. Adv. Mater. Sci. Eng. 2019;2019:3429527.

    Not in our library10.1155/2019/3429527

  3. 3.
  4. 4.

    Lauritano D., Limongelli L., Moreo G., Favia G., Carinci F. Nanomaterials for Periodontal Tissue Engineering: Chitosan-Based Scaffolds. A Systematic Review. Nanomaterials. 2020;10:605.

    Not in our library10.3390/nano10040605

  5. 5.

    Tan H.-L., Kai D., Pasbakhsh P., Teow S.-Y., Lim Y.-Y., Pushpamalar J. Electrospun cellulose acetate butyrate/polyethylene glycol (CAB/PEG) composite nanofibers: A potential scaffold for tissue engineering. Colloids Surf. B Biointerfaces. 2020;188:110713.

    Not in our library10.1016/j.colsurfb.2019.110713

  6. 6.

    Biswal T. Biopolymers for tissue engineering applications: A review. Mater. Today: Proc. 2020;41:397-402.

    Not in our library10.1016/j.matpr.2020.09.628

  7. 7.

    Chan B.P., Leong K.W. Scaffolding in tissue engineering: General approaches and tissue-specific considerations. Eur. Spine J. 2008;17:467-479.

    Not in our library10.1007/s00586-008-0745-3

  8. 8.

    Junior A.L., Pinheiro C.C.G., Fernandes T.L., Bueno D.F. The use of human dental pulp stem cells for in vivo bone tissue engineering: A systematic review. J. Tissue Eng. 2018;9:2041731417752766.

    Not in our library10.1177/2041731417752766

  9. 9.

    Dehghan M., Mehrizi M.K., Nikukar H. Modeling and optimizing a polycaprolactone/gelatin/polydimethylsiloxane nanofiber scaffold for tissue engineering: Using response surface methodology. J. Text. Inst. 2021;112:482-493.

    Not in our library10.1080/00405000.2020.1766317

  10. 10.

    Dutta R.C., Dey M., Dutta A.K., Basu B. Competent processing techniques for scaffolds in tissue engineering. Biotechnol. Adv. 2017;35:240-250.

    Not in our library10.1016/j.biotechadv.2017.01.001

  11. 11.

    Mathew A., Augustine R., Kalarikal N., Thomas S. Tissue Engineering: Principles, Recent Trends and the Future. Nanomedicine and Tissue Engineering. 2016;31-82.

    Not in our library10.1201/b19867-3

  12. 12.

    Castells-Sala C., Alemany-Ribes M., Fernández-Muiños T., Recha-Sancho L., López-Chicón P., Aloy-Reverté C., Caballero-Camino J., Márquez-Gil A., Semino C.E. Current applications of tissue engineering in biomedicine. J. Biochips Tiss. Chips. 2013;S2:1.

    Not in our library10.4172/2153-0777.s2-004

  13. 13.

    Dufey V., Tacheny A., Art M., Becken U., De Longueville F. Expansion of human bone marrow-derived mesenchymal stem cells in BioBLU 0.3 c single-use bioreactors. Appl. Note. 2016;305:1-8.

    Not in our library

  14. 14.

    Ye L., Swingen C., Zhang J. Induced Pluripotent Stem Cells and Their Potential for Basic and Clinical Sciences. Curr. Cardiol. Rev. 2013;9:63-72.

    Not in our library10.2174/157340313805076278

  15. 15.

    Damjanov I., Damjanov I. Inflammation and Repair. Pathology Secrets. 2009;19-37.

    Not in our library

  16. 16.

    Akter F., Akter F. Principles of Tissue Engineering. Tissue Engineering Made Easy. 2016;3-16.

    Not in our library

  17. 17.

    Alaribe F.N., Manoto S.L., Motaung S.C.K.M. Scaffolds from biomaterials: Advantages and limitations in bone and tissue engineering. Biologia. 2016;71:353-366.

    Not in our library10.1515/biolog-2016-0056

  18. 18.

    Perić Kačarević Ž., Rider P., Alkildani S., Retnasingh S., Pejakić M., Schnettler R., Gosau M., Smeets R., Jung O., Barbeck M. An introduction to bone tissue engineering. Int. J. Artif. Organs. 2019;43:69-86.

    Not in our library10.1177/0391398819876286

  19. 19.

    Roseti L., Parisi V., Petretta M., Cavallo C., Desando G., Bartolotti I., Grigolo B. Scaffolds for Bone Tissue Engineering: State of the art and new perspectives. Mater. Sci. Eng. C. 2017;78:1246-1262.

    Not in our library10.1016/j.msec.2017.05.017

  20. 20.

    Verma P., Verma V. Concepts of Tissue Engineering. Animal Biotechnology. 2020;295-307.

    Not in our library

  21. 21.

    Alonzo M., Primo F.A., Kumar S.A., Mudloff J.A., Dominguez E., Fregoso G., Ortiz N., Weiss W.M., Joddar B. Bone tissue engineering techniques, advances, and scaffolds for treatment of bone defects. Curr. Opin. Biomed. Eng. 2020;17:100248.

    Not in our library10.1016/j.cobme.2020.100248

  22. 22.

    Roberts T.T., Rosenbaum A.J. Bone grafts, bone substitutes and orthobiologics: Bone grafts, bone substitutes and orthobiologics the bridge between basic science and clinical advancements in fracture healing. Organogenesis. 2012;8:114-124.

    Not in our library10.4161/org.23306

  23. 23.

    Wong Y.S., Tay C.Y., Wen F., Venkatraman S.S., Tan L.P. Engineered Polymeric Biomaterials for Tissue Engineering. Curr. Tissue Eng. 2012;1:41-53.

    Not in our library10.2174/2211542011201010041

  24. 24.

    Nikolova M.P., Chavali M.S. Recent advances in biomaterials for 3D scaffolds: A review. Bioact. Mater. 2019;4:271-292.

    Not in our library10.1016/j.bioactmat.2019.10.005

  25. 25.

    Gurumurthy B., Janorkar A.V. Improvements in mechanical properties of collagen-based scaffolds for tissue engineering. Curr. Opin. Biomed. Eng. 2021;17:100253.

    Not in our library10.1016/j.cobme.2020.100253

  26. 26.

    Pal S. Mechanical Properties of Biological Materials. Design of Artificial Human Joints & Organs. 2014;23-40.

    Not in our library

  27. 27.
  28. 28.

    Ogneva I.V., Lebedev D., Shenkman B.S. Transversal Stiffness and Young’s Modulus of Single Fibers from Rat Soleus Muscle Probed by Atomic Force Microscopy. Biophys. J. 2010;98:418-424.

    Not in our library10.1016/j.bpj.2009.10.028

  29. 29.

    Nguyen B.V., Wang Q.G., Kuiper N.J., El Haj A.J., Thomas C.R., Zhang Z. Biomechanical properties of single chondrocytes and chondrons determined by micromanipulation and finite-element modelling. J. R. Soc. Interface. 2010;7:1723-1733.

    Not in our library10.1098/rsif.2010.0207

  30. 30.

    Saha K., Keung A.J., Irwin E.F., Li Y., Little L., Schaffer D.V., Healy K.E. Substrate Modulus Directs Neural Stem Cell Behavior. Biophys. J. 2008;95:4426-4438.

    Not in our library10.1529/biophysj.108.132217

  31. 31.

    Chen E., Novakofski J., Jenkins W., O’Brien W. Young’s modulus measurements of soft tissues with application to elasticity imaging. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 1996;43:191-194.

    Not in our library10.1109/58.484478

  32. 32.

    Spedden E., White J.D., Naumova E.N., Kaplan D.L., Staii C. Elasticity Maps of Living Neurons Measured by Combined Fluorescence and Atomic Force Microscopy. Biophys. J. 2012;103:868-877.

    Not in our library10.1016/j.bpj.2012.08.005

  33. 33.

    Tran T., Hamid Z., Cheong K. A Review of Mechanical Properties of Scaffold in Tissue Engineering: Aloe Vera Composites. J. Phys. Conf. Ser. 2018;1082:012080.

    Not in our library10.1088/1742-6596/1082/1/012080

  34. 34.

    Collinsworth A.M., Zhang S., Kraus W.E., Truskey G.A. Apparent elastic modulus and hysteresis of skeletal muscle cells throughout differentiation. Am. J. Physiol. Physiol. 2002;283:C1219-C1227.

    Not in our library10.1152/ajpcell.00502.2001

  35. 35.

    Nguyen-Truong M., Li Y., Wang Z. Mechanical Considerations of Electrospun Scaffolds for Myocardial Tissue and Regenerative Engineering. Bioengineering. 2020;7:122.

    Not in our library10.3390/bioengineering7040122

  36. 36.

    Zhang X.-Y., Fang G., Zhou J. Additively Manufactured Scaffolds for Bone Tissue Engineering and the Prediction of their Mechanical Behavior: A Review. Materials. 2017;10:50.

    Not in our library10.3390/ma10010050

  37. 37.

    Sharma R., Kirsch R., Valente K., Perez M., Willerth S. Physical and Mechanical Characterization of Fibrin-Based Bioprinted Constructs Containing Drug-Releasing Microspheres for Neural Tissue Engineering Applications. Processes. 2021;9:1205.

    Not in our library10.3390/pr9071205

  38. 38.

    Ezhilarasu H., Ramalingam R., Dhand C., Lakshminarayanan R., Sadiq A., Gandhimathi C., Ramakrishna S., Bay B.H., Venugopal J.R., Srinivasan D.K. Biocompatible Aloe vera and Tetracycline Hydrochloride Loaded Hybrid Nanofibrous Scaffolds for Skin Tissue Engineering. Int. J. Mol. Sci. 2019;20:5174.

    Not in our library10.3390/ijms20205174

  39. 39.

    Place E.S., Evans N.D., Stevens M.M. Complexity in biomaterials for tissue engineering. Nat. Mater. 2009;8:457-470.

    Not in our library10.1038/nmat2441

  40. 40.

    O’Brien F.J. Biomaterials & scaffolds for tissue engineering. Mater. Today. 2011;14:88-95.

    Not in our library10.1016/s1369-7021(11)70058-x

All 253 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.